Skip to content

Thomas Romo, M.D.

NPI 1215093927ActiveIndividual· Plastic Surgery, Plastic Surgery Within the Head and Neck· New York, NY

Plastic Surgery, Plastic Surgery Within the Head and Neck (M.D.) in New York, New York, licensed in NY, with an NPI issued in December 2006. Part D covered 79 prescriptions written in 2024, 94% of them generic. Revance Therapeutics, Inc. reported $512.65 in payments in 2024, mostly food and beverage.

Overview

NPI1215093927
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedDec 28, 2006
Last updated in NPPESNov 9, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)79 · 79 30-day fills
Patients15
Total drug cost$706.18
Generic share94% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$512.65 · 4 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Revance Therapeutics, Inc.$512.654

What the 2024 payments were for

  • Food and Beverage$512.65 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Plastic Surgery, Plastic Surgery Within the Head and Neck providers in New York

All Plastic Surgery, Plastic Surgery Within the Head and Neck providers in New York